Acrivon Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	34.06	41.5	39.82	36.02	29.52	99.6
Short-Term Investments	63.67	77.08	139.66	91.44	98.23	-
Cash & Short-Term Investments	97.74	118.58	179.48	127.46	127.75	99.6
Cash Growth	-34.68%	-33.93%	40.81%	-0.23%	28.26%	6192.04%
Other Current Assets	1.48	1.86	2.15	2.23	4.34	0.81
Total Current Assets	99.22	120.45	181.63	129.69	132.1	100.41
Net Property, Plant & Equipment	6.91	7.42	8.03	7.91	6.86	5.79
Long-Term Investments	-	-	5.09	-	41.88	-
Other Long-Term Assets	1.7	1.86	1.85	0.67	0.39	0.39
Total Assets	107.83	129.72	196.59	138.27	181.23	106.59
Accounts Payable	1.16	2.28	0.76	5.05	0.9	0.96
Accrued Expenses	8.74	12.22	15.4	7.38	4.89	1.29
Current Portion of Leases	1.15	1.17	1.06	0.88	0.73	0.66
Total Current Liabilities	11.05	15.66	17.21	13.3	6.52	2.91
Long-Term Leases	1.26	1.54	2.59	3.77	4.24	4.96
Total Long-Term Liabilities	1.26	1.54	2.59	3.77	4.24	4.96
Total Liabilities	12.32	17.2	19.8	17.07	10.75	7.88
Common Stock	0.04	0.03	0.03	0.02	0.02	0
Additional Paid-in Capital	389.4	387.26	373.28	237.68	226.58	1.05
Accumulated Other Comprehensive Income	0	0.11	0.45	-0.08	-0.1	-
Retained Earnings	-293.92	-274.88	-196.98	-116.42	-56.03	-24.87
Total Common Shareholders' Equity	95.52	112.52	176.79	121.2	170.48	-23.81
Minority Interest	-	-	-	-	-	122.52
Shareholders' Equity	95.52	112.52	176.79	121.2	170.48	98.71
Total Liabilities & Equity	107.83	129.72	196.59	138.27	181.23	106.59
Total Debt	2.42	2.71	3.65	4.64	4.96	5.63
Net Cash (Debt)	95.32	115.87	175.84	122.81	122.79	93.98
Net Cash Growth	-17.74%	-34.10%	43.17%	0.02%	30.66%	5836.51%
Net Cash Per Share	2.47	3.01	5.20	5.56	29.79	53.90
Book Value	95.52	112.52	176.79	121.2	170.48	-23.81
Book Value Per Share	2.47	2.92	5.23	5.49	41.36	-13.66
Tangible Book Value	95.52	112.52	176.79	121.2	170.48	-23.81
Tangible Book Value Per Share	2.47	2.92	5.23	5.49	41.36	-13.66

Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q